Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
glaxosmithkline
3
×
life sciences
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
abbvie
alzheimer's disease
bausch health
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
crispr
detroit blog main
detroit top stories
dihydroergotamine
eli lilly
indiana blog main
indiana top stories
merck
migraine
multiple myeloma
national
national top stories
san diego blog main
san diego top stories
satsuma pharmaceuticals
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
What
companies
3
×
bio
drug
leading
roundup
activity
approval
biogen’s
biopharmaceutical
biotech
black
continue
convo
days
debut
diamond
diamond’s
dog
earlier
failures
firm
hasn’t
indication
ipo
ipos
life
line
littered
mammoth
march
migraine
moves
nash
new
news
ohana’s
pfizer
place
pop
prep
Language
unset
Current search:
glaxosmithkline
×
companies
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
